← Scroll for more →
Seres Therapeutics, Inc. (MCRB)
Pharmaceutical Preparations
Latest Price
$1.80
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
3.56
P/B Ratio
0.51
Valuation metrics
adjust assumptions →EPS: $0.64
Book value / share: $4.63
Formula: √(22.5 × EPS × BVPS)
Graham Number
$8.16
+353% upside
EPS: $0.64
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$9.60
+433% upside
Institutional Ownership
23.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Flagship Pioneering, LLC | 1.16M | $9.0M | 11.76% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 287.8K | $2.0M | 2.93% | -6.4K | 2026-06-30 |
| Marshall Wace, LLP | 172.2K | $1.0M | 1.75% | +32.7K | 2026-06-30 |
| Vontobel Holding Ltd. | 123.0K | -- | 1.25% | -15.5K | 2026-06-30 |
| BlackRock, Inc. | 111.0K | -- | 1.13% | +9.0K | 2026-06-30 |
| Geode Capital Management, LLC | 80.0K | -- | 0.81% | +5.1K | 2026-06-30 |
| Citadel Advisors LLC | 54.0K | -- | 0.55% | -5.5K | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 48.7K | -- | 0.50% | +9.0K | 2026-06-30 |
| State Street Corp | 33.9K | -- | 0.34% | -- | 2026-06-30 |
| Lion Point Capital, LP | 31.6K | -- | 0.32% | -- | 2026-06-30 |